𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The function of dog models in developing gene therapy strategies for human health

✍ Scribed by Keri L. Nowend; Alison N. Starr-Moss; Keith E. Murphy


Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
253 KB
Volume
22
Category
Article
ISSN
0938-8990

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development of adenovirus immobilization
✍ Wei-Wen Hu; Michael W. Lang; Paul H. Krebsbach πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 280 KB

## Abstract ## Background Regenerative gene therapy using viral vectors enables transduced cells to express bioactive factors __in vivo__. Viral delivery with spatial control can enhance transduction efficiency and may limit systemic infection. Consequently, we tethered biotinylated adenovirus via

Development of gene therapy-based strate
✍ Piroska E. Rakoczy; Wei-Yong Shen; May Lai; Fabienne Rolling; Ian J. Constable πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from

Gene-directed enzyme prodrug therapy for
✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 310 KB πŸ‘ 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar

Combination of oncolytic adenovirotherap
✍ Masayoshi Hioki; Shunsuke Kagawa; Toshiya Fujiwara; Ryo Sakai; Toru Kojima; Yuic πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 292 KB

## Abstract Cancer gene therapy and oncolytic virotherapy have been studied extensively. However, their clinical application is hampered by their weak anticancer activity. We previously constructed a replicating adenovirus (OBP‐301, Telomelysin), in which the human telomerase reverse transcriptase